Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Shifnaz N P"'
Publikováno v:
International Journal of Research and Review. 10:45-51
Dapagliflozin is a sodium-glucose co-transporter 2 inhibitor (SGLT2), used in decreasing the blood sugar levels in Type 2 diabetes mellitus patients by boosting urine glucose excretion, which also reduces the incidence of major adverse cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::568ae32741942413801d7a9818f7c395
https://doi.org/10.52403/ijrr.20230106
https://doi.org/10.52403/ijrr.20230106
